The RXO acquisition announced by C.H. Robinson and RXO on October 5, 2026 is a proposed stock-and-cash transaction with an implied value of $5.8 billion. For shareholders, the important detail is the payment formula: the standard consideration combines money with an ownership interest in C.H. Robinson.
RXO acquisition: what the standard payment contains
The companies say each RXO share would receive $17.25 in cash and 0.0856 shares of C.H. Robinson common stock. Their release describes an implied total value of $30.25 per share, using C.H. Robinson’s 16-day volume-weighted average price of $151.88 as of October 2.
CapKet explanation: A volume-weighted average is a historical price measure, not a live quotation. The release’s reference value therefore should not be presented as today’s RXO price or as a guaranteed cash payout. The share component has a value that depends on the price of the shares received.
Why choosing cash does not remove every condition
The announcement also describes all-cash and all-stock election alternatives. Those choices are subject to proration and adjustment procedures intended to keep the aggregate transaction consideration at approximately 57% cash and 43% stock.
Proration means an election is subject to allocation rules rather than an unconditional promise that every shareholder receives exactly the option requested. The detailed transaction documents matter for the final mechanics. This report does not calculate any particular shareholder’s eventual allocation.
The agreement is not a completed acquisition
The companies expect completion in the first half of 2027. Regulatory approval, RXO shareholder approval and customary closing conditions remain necessary. A signed agreement and an expected closing window are different milestones from a completed transaction.
The release says a registration statement on Form S-4, including RXO proxy material and a C.H. Robinson prospectus, is intended to be filed. CapKet has checked the announcement, not the full merger agreement or a subsequently filed proxy package. Readers should use those documents when available for voting instructions, conditions and election procedures.
What this means for following the story
CapKet analysis: Separate three questions: what has been agreed, what approvals remain, and what the consideration would be worth when received. None is answered by a headline announcing the overall transaction value alone. No share-price reaction, arbitrage return or recommendation to buy either company’s stock is claimed.
For another completed-versus-proposed distinction, see our report on Dynatrace’s completed Arize acquisition.
Primary evidence: the October 5 company announcement hosted by RXO, observed October 6 at approximately 01:03 IST. The source’s US announcement date is retained; this article does not describe an October 6 US announcement.